HLB Life Science Co. Ltd (067630) — Long-term Investment Intensity
HLB Life Science Co. Ltd (067630) has a Long-term Investment Intensity of 27.1% as of September 2019. Long-term investments of ₩96.14 Billion represent 27.1% of total assets of ₩354.61 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of HLB Life Science Co. Ltd to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
HLB Life Science Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how HLB Life Science Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 27.1%, reflecting long-term investments of ₩96.14 Billion against total assets of ₩354.61 Billion KRW. For the complete balance sheet picture, see HLB Life Science Co. Ltd assets under control.
Annual Long-term Investment Intensity for HLB Life Science Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for HLB Life Science Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read HLB Life Science Co. Ltd (067630) financial obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 5.3% | ₩20.61 Billion | ₩386.26 Billion | ▼ -13.0 pp |
| 2017 | 18.3% | ₩18.12 Billion | ₩99.02 Billion | ▼ -3.8 pp |
| 2016 | 22.1% | ₩18.30 Billion | ₩82.68 Billion | ▲ +16.1 pp |
| 2015 | 6.0% | ₩2.58 Billion | ₩42.70 Billion | ▲ +0.3 pp |
| 2014 | 5.7% | ₩1.91 Billion | ₩33.39 Billion | — |